Capsule Endoscopy

CapsoVision, Inc. is a medical device manufacturer specializing in capsule endoscopy systems for small bowel imaging. The company's flagship product, CapsoCam Plus®, is an FDA-cleared capsule endoscopy system featuring four laterally oriented onboard cameras that capture a complete 360° panoramic view of the small bowel with high-resolution imaging. Unlike traditional capsule endoscopy systems, CapsoCam Plus eliminates the need for external data recorders, belts, or bulky equipment, improving patient comfort and convenience while reducing procedure time for clinical staff. The system is FDA-cleared for remote ingestion and approved for pediatric patients ages 2 and up, expanding diagnostic capabilities across adult and pediatric gastrointestinal populations. CapsoCloud, the company's cloud-based software platform, enables streamlined image review and result access from any location, eliminating capital equipment costs and maintenance burdens. The platform includes automated invoicing and auto-reordering capabilities designed to simplify clinic workflow and reduce administrative overhead. CapsoVision targets gastroenterology practices, hospital systems, and specialized GI centers seeking improved diagnostic yield, faster image interpretation, and enhanced patient satisfaction. The company maintains a US headquarters in Saratoga, California, and supports international markets through a network of authorized distributors. Products are manufactured to medical device standards appropriate for diagnostic imaging and are FDA-cleared for clinical use.

Biosys Biyomedikal Mühendislik A.Ş. is a Turkish medical device manufacturer established in 2012 and headquartered in Ankara with manufacturing facilities in Batman. The company specializes in the research, development, design, and manufacturing of critical care and ICU medical equipment. With approximately 62 employees and reported annual revenue of $8.1 million, Biosys is an R&D-driven organization focused on enhancing global access to quality medical technology. The company manufactures a comprehensive portfolio of life support and respiratory devices including mechanical ventilators (Biyovent ICU ventilator), high-flow oxygen therapy systems, humidifiers with integrated nebulization, and advanced neuro-monitoring devices for intraoperative neural function assessment. Biosys is recognized for innovative technologies including neonatal ventilation systems and swallowable capsules for endoscopic applications. The company serves pediatric and neonatal ICU units, operating rooms (general surgery and otolaryngology), and general intensive care environments. Biosys provides comprehensive engineering services covering product development, mechanical and electrical analysis, and system testing. The company exports internationally to Romania, Brazil, Kazakhstan, and Thailand, and participates in healthcare industry trade fairs.

IntroMedic Co., Ltd. is a South Korean medical technology company founded in 2004, specializing in capsule endoscopy systems and minimally invasive endoscopic diagnostic equipment. The company manufactures and markets the MiroCam® Capsule Endoscope System for high-resolution gastrointestinal imaging, the E.G. Scan™ flexible video esophagoscope for esophageal and gastric visualization, and EndoClot hemostasis equipment for bleeding control. IntroMedic holds ISO 13485 certification and FDA 510(k) clearance, serving hospitals and clinics globally with approximately 70 employees. The company is committed to advancing minimally invasive endoscopy solutions for improved diagnostic accuracy and patient outcomes in gastroenterology and related specialties.

AnX Robotica Corp is a medical technology company headquartered in Plano, Texas, specializing in robotic capsule endoscopy and advanced gastrointestinal diagnostic systems. Founded in 2019, the company develops non-invasive and minimally invasive solutions for diagnosing and managing gastrointestinal diseases utilizing magnetic robotic control, artificial intelligence, and micro-optical imaging technologies. The NaviCam® GI Diagnostic Platform represents the company's integrated suite of advanced capsule-based diagnostic technologies. AnX serves gastroenterologists and GI clinicians with FDA-cleared products including NaviCam SB (small bowel capsule endoscopy with ProScan AI-assisted reading tool), NaviCam T (esophageal visualization with real-time tethered control), MotiliCap (whole-gut transit testing and motility monitoring), NaviCam Xpress (stomach lesion detection), NaviCam Colon (colonic visualization), and IntraMarX (magnetic localization markers). With over 200 patents, AnX is positioned as a leader in robotic capsule endoscopy technology, focusing on improving diagnostic accuracy, reducing clinician reading time, and enhancing patient outcomes while reducing healthcare costs.

Cyted Health is a Cambridge-based biotechnology company specializing in gastrointestinal molecular diagnostics for early detection and monitoring of esophageal conditions. Founded in 2020 as a University of Cambridge spinout, the company develops non-endoscopic diagnostic platforms that enable minimally invasive cell collection from the esophagus. The flagship product, EndoSign®, is an FDA-cleared capsule sponge device that provides safe, accessible esophageal sampling with full tissue coverage, significantly improving patient comfort and access compared to traditional endoscopy. Cyted Health combines proprietary biomarker discovery with AI-driven diagnostic tools to detect Barrett's Esophagus, esophageal neoplasia, and early-stage esophageal cancer. The company has completed over 35,000 tests through the UK National Health Service and operates CLIA-accredited laboratories in both the UK and US, serving healthcare systems with evidence-based screening and surveillance solutions for gastrointestinal malignancy prevention.